Impact of Phonatory and Facial Morphology Disorders, on the Quality of Life of Adolescents With Pierre Robin Sequence
NCT03194178 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2025-05-06
Summary
The study team has made the hypothesis that the intensity of the phonatory disorders (rhinolalia), and of the maxillo-mandibular growth anomalies (facial morphology), may have negative effects on the quality of life of adolescents with Pierre Robin sequence.
The investigators also want to assess the impact of 2 different surgical protocols of closure of the cleft palate (1 or 2 step(s)), on the current phonatory and morphology aspects. These 2 protocols were performed, by 2 parisian clinical teams, that have now been merged at Necker hospital.
Conditions
- Pierre Robin Syndrome
Interventions
- OTHER
-
Pierre Robin sequence patients
4 questionnaires will be completed by the patient : * "Kidscreen 52" (generic quality of life questionnaire) * "Voice Handicap Index" : VHI-9i (specific quality of life questionnaire) * "Child Oral Health Impact Profile" : COHIP (specific quality of life questionnaire) * "MDI-C" (composite depression scale for minors)
Sponsors & Collaborators
-
Imagine Institute
lead OTHER
Principal Investigators
-
Véronique Abadie, Pr · Necker - Enfants Malades Hospital
Eligibility
- Min Age
- 12 Years
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-07-31
- Primary Completion
- 2019-07-31
- Completion
- 2019-07-31
Countries
- France
Study Locations
More Related Trials
-
Efficacy Study of Folinic Acid to Improve Mental Development of Children With Down Syndrome
NCT00294593 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Sirolimus to Treat Cowden Syndrome and Other PTEN Hamartomatous Tumor Syndromes
NCT00971789 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy Study of Sirolimus in Complicated Vascular Anomalies
NCT00975819 ·Status: COMPLETED ·Phase: PHASE2
-
A Trial of Metformin in Individuals With Fragile X Syndrome
NCT03479476 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Efficacy of Rapamycin (Sirolimus) in the Treatment of BRBNS, Hereditary or Sporadic Venous Malformation
NCT03767660 ·Status: UNKNOWN ·Phase: PHASE4
-
Study to Evaluate the Safety and Efficacy of Phenoptin™ in Subjects With Phenylketonuria Who Have Elevated Phenylalanine Levels
NCT00104247 ·Status: COMPLETED ·Phase: PHASE3
-
Pirfenidone in Treating Young Patients With Neurofibromatosis Type 1 and Plexiform Neurofibromas
NCT00053937 ·Status: COMPLETED ·Phase: PHASE1
-
Metformin in Children With Fragile X Syndrome
NCT05120505 ·Status: RECRUITING ·Phase: PHASE4
-
Combining Lovastatin and a Parent-Implemented Language Intervention for Fragile X Syndrome
NCT02642653 ·Status: COMPLETED ·Phase: PHASE4
-
Sirolimus for Cowden Syndrome With Colon Polyposis
NCT04094675 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of JNT-517 in Participants With Phenylketonuria (PKU)
NCT06971731 ·Status: RECRUITING ·Phase: PHASE3
-
Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of CYH33 in Patients With PIK3CA-related Overgrowth Spectrum (PROS) and PIK3CA-related Vascular Malformations (PRVM)
NCT06975618 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Efficacy and Safety of Lenalidomide as a Treatment for Recurrent or Refractory POEMS Syndrome Trial
NCT02193698 ·Status: COMPLETED ·Phase: PHASE2
-
A 2-Period Crossover Study of BPN14770 in Adults Males With Fragile X Syndrome
NCT03569631 ·Status: COMPLETED ·Phase: PHASE2
-
Survey Study and Records Review of Treatment Outcomes in Freeman-Sheldon Syndrome
NCT01144741 ·Status: TERMINATED
-
Percutaneous Administration of Sirolimus in the Treatment of Superficial Complicated Vascular Anomalies
NCT04921722 ·Status: RECRUITING ·Phase: PHASE4
-
Prospective Evaluation of the Efficacy of Sirolimus (Rapamune®) in the Treatment of Severe Arteriovenous Malformations
NCT02042326 ·Status: RECRUITING ·Phase: PHASE2
-
A Study of KRN23 in Subjects With X-linked Hypophosphatemic Rickets/Osteomalacia
NCT02181764 ·Status: COMPLETED ·Phase: PHASE1
-
Microcephaly, Fanconi Anemia and Praxial Disorders
NCT04656171 ·Status: WITHDRAWN ·Phase: NA
-
An Open-Label Extension Study of Palovarotene Treatment in Fibrodysplasia Ossificans Progressiva (FOP)
NCT02279095 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of the Efficacy, Safety, and Tolerability of Sarizotan in Rett Syndrome With Respiratory Symptoms
NCT02790034 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Long-term Safety and Efficacy Outcome Study Comparing Children Previously Enrolled in Study ROPP-2008-01 for the Prevention of Retinopathy of Prematurity (ROP)
NCT02386839 ·Status: COMPLETED ·Phase: PHASE2
-
Neuroimaging and Neurocognitive Assessment and Response to Sapropterin Dihydrochloride Treatment in Phenylketonuria
NCT01412437 ·Status: WITHDRAWN ·Phase: NA
-
Efficacy of Rapamycin (Sirolimus) in the Treatment of Peutz-Jeghers Syndrome
NCT03781050 ·Status: UNKNOWN ·Phase: PHASE4
-
Sirolimus Effect on Hypertrophic Syndromes Related Gene PIK3CA
NCT02443818 ·Status: COMPLETED ·Phase: PHASE2